Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

Gitte Vrelits Sørensen, Patricia A Ganz, Steven W Cole, Lars A Pedersen, Henrik Toft Sørensen, Deirdre Cronin-Fenton, Jens Peter Garne, Peer Michael Christiansen, Timothy Lash, Thomas P Ahern

Research output: Contribution to journalJournal articleResearchpeer-review

72 Citations (Scopus)
Original languageEnglish
JournalJournal of Clinical Oncology
Volume31
Issue number18
Pages (from-to)2265-72
Number of pages8
ISSN0732-183X
DOIs
Publication statusPublished - 6 May 2013

Keywords

  • Adrenergic beta-Antagonists
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Breast Neoplasms
  • Denmark
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Proportional Hazards Models
  • Prospective Studies
  • Registries
  • Risk Assessment
  • Risk Factors

Fingerprint

Dive into the research topics of 'Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study'. Together they form a unique fingerprint.

Cite this